Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 0.34
-21.2 %
$ 8.12 M
Market Cap
-0.22
P/E
PRPH - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities PRPH - ProPhase Labs, Inc.
5.76 M
LAST VALUE
-59.52%
2 YEAR CAGR
20.18%
5 YEAR CAGR
31.55%
10 YEAR CAGR